The expression of PD-L1 and PD-L2 in dermal fibroblasts is upregulated by activated T cells in the skin of the alopecia areata mouse model, suggesting that gene modification of the PD-1/PD-L1 checkpoint pathway provides an immunotherapeutic strategy against skin immune diseases [31]. The gene discussed is CD274; the disease is alopecia areata.